AlphaStocks
6.3
Consider Buy

Chemed Corp (CHE)

As of Sep 20, 2026, Chemed Corp (CHE) scores 6.3/10 on AlphaStocks' five-model composite, #39 of 168 Health Care stocks. At $503, CHE trades 9% below its model fair value of $551.

Health Care / Health Care Services

S&P MidCap 400

$503.05

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#39out of 168 in Health Care

Is CHEMED CORP a Good Investment in 2026?

CHEMED CORP (CHE) scores 6.3 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates CHEMED CORP as Attractive (5/9). However, the Lynch model rates it Caution — PEG 1.4 · Fast Grower. CHEMED CORP currently trades 9% below its estimated fair value of $551. CHEMED CORP ranks #39 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E21.4ROE-9.6Market Cap7B

Estimated Fair Value

$550.669% below

Trading slightly below estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Neutral

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Caution

PEG 1.4 · Fast Grower

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is CHEMED CORP (CHE) a good investment?
As of Sep 20, 2026, Chemed Corp (CHE) scores 6.3/10 on AlphaStocks' five-model composite, #39 of 168 Health Care stocks. At $503, CHE trades 9% below its model fair value of $551. That is a middle-of-the-pack score with no strong signal either way.
What is CHEMED CORP's Piotroski F-Score?
CHEMED CORP's Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is CHE overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $551, CHE appears undervalued. The stock currently trades 9% below its estimated fair value. Trading slightly below estimated fair value.
How does CHE compare to other Health Care stocks?
CHEMED CORP ranks #39 out of 168 stocks in the Health Care sector, placing it in the top 23% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about CHE?
AlphaStocks evaluates CHE using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Neutral; Lynch: Caution. These models are combined into a single composite score of 6.3/10.

Similar Stocks

DVAMDDGX

Compare CHE with

CHE vs DVACHE vs MDCHE vs DGX

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer